Financials

  • Market Capitalization 548.14 M
  • Employee 40
  • Founded 2022
  • CEO N/A
  • Website www.zurabio.com
  • Headquarter Cayman Islands
  • FIGI UNKNOWN
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.94
Rapporto prezzo/fatturato
100.37

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2860
DRUG
Bright Minds Biosciences Inc. - common stock
72.81 USD-2.32%-5.50%+1.70%+85.83%555.96 M USD
2863
PROK
ProKidney Corp. - Class A Ordinary Shares
1.83 USD+0.55%+15.09%+19.61%-12.02%553.25 M USD
2865
OVID
Ovid Therapeutics Inc. - Common Stock
2.80 USD-4.44%+0.36%+21.74%+124.00%546.83 M USD
2870
ARTV
Artiva Biotherapeutics, Inc. - Common Stock
11.09 USD-7.12%+2.40%+10.90%+166.59%542.19 M USD

Notizie